The Contribution of Spirulina Platensis Supplementation on COVID-19 Prevention and Hospitalization
Elias E Mazokopakis, Maria G Papadomanolaki
European Journal of Medical and Health Sciences, doi:10.24018/ejmed.2022.4.3.1355
We suggested the administration of Spirulina to 186 Greek individuals, non-vaccinated against the disease for various reasons, with known sociodemographic data, lifestyle, and medical history (recorded in structured form). These persons met the following inclusion criteria: 1) age 30-60 years, 2) negative history for drug or food allergy, 3) absence of diabetes mellitus type 1 or 2, cancer, renal failure, liver dysfunction, congestive heart failure, or chronic obstructive pulmonary disease, 4) no treatment with corticosteroids, blood thinners, immunosuppressants, radiotherapy, or chemotherapy, 5) absence of phenylketonuria, 6) no pregnancy or lactation, and 7) serum 25(OH)D levels > 20 ng/mL. Among the 186 (87 men, 99 women) unvaccinated individuals, 102 agreed, giving written consent with a signed informed consent form, to receive orally 6 gr of high-quality Spirulina (Arthrospira platensis) supplementation (Hellenic Spirulina Net: Production unit: Thermopigi, Sidorokastro, Serres, Central Macedonia, Greece) daily for 6 months: June-
References
Chia, Kok, Chew, Low, Show, Can algae contribute to the war with Covid-19?, Bioengineered
Mazokopakis, Starakis, Papadomanolaki, Mavroeidi, Ganotakis, The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study, J Sci Food Agric
Ratha, Renuka, Rawat, Bux, Prospective options of algaederived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases, Nutrition
{ 'indexed': {'date-parts': [[2024, 8, 29]], 'date-time': '2024-08-29T05:48:07Z', 'timestamp': 1724910487703},
'reference-count': 3,
'publisher': 'European Open Science Publishing',
'issue': '3',
'license': [ { 'start': { 'date-parts': [[2022, 5, 30]],
'date-time': '2022-05-30T00:00:00Z',
'timestamp': 1653868800000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'http://creativecommons.org/licenses/by/4.0'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>\n'
'Background & Aims: Spirulina is a filamentous cyanobacterium known for its high '
'nutritional value and therapeutic properties. The aim of this study was to investigate the '
'role of Spirulina supplementation on coronavirus disease 2019 (COVID-19) prevention and '
'hospitalization.\n'
'\n'
'\n'
'Methods: We studied the state of health among 186 (median age: 47, range: 30-60 years) Greek '
'individuals, non-vaccinated against the COVID-19, for 6 months. Among these, 102 unvaccinated '
'individuals received orally 6 g Spirulina (Arthrospira platensis) daily for 6 months. '
'Anthropometric characteristics (height, weight, body mass index / BMI), systolic and '
'diastolic blood pressure, complete blood count and biochemical assessments, were recorded and '
'measured before Spirulina supplementation.\n'
'\n'
'\n'
'Results: Among the 102 unvaccinated individuals who received Spirulina, only 14 (13.7%) '
'contracted SARS-CoV2 (confirmed Delta variant) with mild symptoms and 2 (1.9%) needed '
'hospitalization because of acute viral gastroenteritis. In contrast, among the 84 '
'unvaccinated individuals who did not receive Spirulina, 62 (73.8%) contracted SARS-CoV2 '
'(confirmed Delta variant) with mild symptoms and 17 (20.2%) needed hospitalization. None of '
'the hospitalized patients died.\n'
'\n'
'\n'
'Conclusions: Spirulina supplementation at a dose of 6 g daily can contribute to the war '
'against SARS-CoV2, preventing COVID-19 and reducing the need for hospitalization.\n'
'</jats:p>',
'DOI': '10.24018/ejmed.2022.4.3.1355',
'type': 'journal-article',
'created': {'date-parts': [[2022, 6, 2]], 'date-time': '2022-06-02T18:01:04Z', 'timestamp': 1654192864000},
'page': '82-83',
'source': 'Crossref',
'is-referenced-by-count': 3,
'title': 'The Contribution of Spirulina Platensis Supplementation on COVID-19 Prevention and '
'Hospitalization',
'prefix': '10.24018',
'volume': '4',
'author': [ {'given': 'Elias E.', 'family': 'Mazokopakis', 'sequence': 'first', 'affiliation': []},
{'given': 'Maria G.', 'family': 'Papadomanolaki', 'sequence': 'additional', 'affiliation': []}],
'member': '10105',
'published-online': {'date-parts': [[2022, 5, 30]]},
'reference': [ { 'key': '22536',
'doi-asserted-by': 'crossref',
'unstructured': 'Mazokopakis EE, Starakis IK, Papadomanolaki MG, Mavroeidi NG, Ganotakis '
'ES. The hypolipidaemic effects of Spirulina (Arthrospira platensis) '
'supplementation in a Cretan population: a prospective study. J Sci Food '
'Agric. 2014; 94(3): 432-437.',
'DOI': '10.1002/jsfa.6261'},
{ 'key': '22537',
'doi-asserted-by': 'crossref',
'unstructured': 'Ratha SK, Renuka N, Rawat I, Bux F. Prospective options of algae-derived '
'nutraceuticals as supplements to combat COVID-19 and human coronavirus '
'diseases. Nutrition. 2021; 83: 111089.',
'DOI': '10.1016/j.nut.2020.111089'},
{ 'key': '22538',
'doi-asserted-by': 'crossref',
'unstructured': 'Chia WY, Kok H, Chew KW, Low SS, Show PL. Can algae contribute to the '
'war with Covid-19? Bioengineered. 2021; 12(1): 1226-1237.',
'DOI': '10.1080/21655979.2021.1910432'}],
'container-title': 'European Journal of Medical and Health Sciences',
'original-title': [],
'link': [ { 'URL': 'https://www.ej-med.org/index.php/ejmed/article/download/1355/810',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.ej-med.org/index.php/ejmed/article/download/1355/810',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 6, 2]],
'date-time': '2022-06-02T18:01:09Z',
'timestamp': 1654192869000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.ej-med.org/index.php/ejmed/article/view/1355'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 5, 30]]},
'references-count': 3,
'journal-issue': {'issue': '3', 'published-online': {'date-parts': [[2022, 5, 2]]}},
'URL': 'http://dx.doi.org/10.24018/ejmed.2022.4.3.1355',
'relation': {},
'ISSN': ['2593-8339'],
'subject': [],
'container-title-short': 'EJMED',
'published': {'date-parts': [[2022, 5, 30]]}}
